Article info

Download PDFPDF

Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial

Authors

  • Aurora Paez-Vega Infectious Diseases Group, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/Reina Sofía University Hospital/University of Cordoba, Cordoba, SpainSpanish Network for Research in Infectious Diseases (REIPI, RD16/0016/0008), Instituto de Salud Carlos III, Madrid, Spain PubMed articlesGoogle scholar articles
  • Sara Cantisan Infectious Diseases Group, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/Reina Sofía University Hospital/University of Cordoba, Cordoba, SpainSpanish Network for Research in Infectious Diseases (REIPI, RD16/0016/0008), Instituto de Salud Carlos III, Madrid, SpainInfectious Diseases Unit, Reina Sofía University Hospital, Cordoba, Spain PubMed articlesGoogle scholar articles
  • José Manuel Vaquero Thoracic Surgery and Lung Transplantation Unit, Reina Sofía University Hospital, Cordoba, Spain PubMed articlesGoogle scholar articles
  • Elisa Vidal Infectious Diseases Group, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/Reina Sofía University Hospital/University of Cordoba, Cordoba, SpainSpanish Network for Research in Infectious Diseases (REIPI, RD16/0016/0008), Instituto de Salud Carlos III, Madrid, SpainInfectious Diseases Unit, Reina Sofía University Hospital, Cordoba, Spain PubMed articlesGoogle scholar articles
  • Antonio Luque-Pineda Clinical Trial Unit, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/Reina Sofía University Hospital/University of Córdoba (SCReN PT17/0017/0032), Cordoba, Spain PubMed articlesGoogle scholar articles
  • María Ángeles Lobo-Acosta Clinical Trial Unit, Virgen del Rocío University Hospital (CTU-HUVR), (SCReNPT13/0002/0010-PT17/0017/0012), Sevilla, Spain PubMed articlesGoogle scholar articles
  • Ana Belén Pérez Infectious Diseases Group, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/Reina Sofía University Hospital/University of Cordoba, Cordoba, SpainMicrobiology Unit, Reina Sofía University Hospital, Cordoba, Spain PubMed articlesGoogle scholar articles
  • Rodrigo Alonso-Moralejo Neumology Service, Instituto de Investigación i+12 Hospital Universitario 12 de Octubre. (REIPI, RD16/0016/0002), Madrid, Spain PubMed articlesGoogle scholar articles
  • David Iturbe Neumology Service, University Hospital Marqués de Valdecilla-IDIVAL (REIPI, RD16/0016/0007), Santander, Spain PubMed articlesGoogle scholar articles
  • Victor Monforte Respiratory Department, Vall d' Hebron Barcelona Hospital Campus. Universitat Autónoma de Barcelona, (REIPI, RD16/0016/0003), Barcelona, SpainCiber Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain PubMed articlesGoogle scholar articles
  • Isabel Otero-Gonzalez Neumology Service, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña (CHUAC) Sergas Universidade da Coruña (UDC), (REIPI, RD16/0016/0006), As Xubias, A Coruna, Spain PubMed articlesGoogle scholar articles
  • Amparo Pastor Lung Transplant Unit, La Fe University and Polytechnic Hospital, Valencia, Spain PubMed articlesGoogle scholar articles
  • Piedad Ussetti Neumology Service, Puerta de Hierro-Majadahonda University Hospital, Majadahonda, Spain PubMed articlesGoogle scholar articles
  • Julian Torre-Cisneros Infectious Diseases Group, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/Reina Sofía University Hospital/University of Cordoba, Cordoba, SpainSpanish Network for Research in Infectious Diseases (REIPI, RD16/0016/0008), Instituto de Salud Carlos III, Madrid, SpainInfectious Diseases Unit, Reina Sofía University Hospital, Cordoba, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sara Cantisan; sacanti{at}hotmail.com
View Full Text

Citation

Paez-Vega A, Cantisan S, Vaquero JM, et al
Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial

Publication history

  • Received March 25, 2019
  • Revised July 12, 2019
  • Accepted July 22, 2019
  • First published August 15, 2019.
Online issue publication 
August 15, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.